VEGFA and neoplasm: Firstly, we focused our attention on tumor angiogenesis and through TargetScan analysis discovered VEGF-A as a potential direct target of miR-CT3; luciferase assay confirmed the predicted binding and the expression of both VEGF-A mRNA and protein resulted reduced in OS cells transfected with a miR-CT3 mimic.